Are there reasons to prefer tetracyclines to macrolides in older patients with community-acquired pneumonia?
- PMID: 23858063
- PMCID: PMC3719784
- DOI: 10.1128/AAC.00828-13
Are there reasons to prefer tetracyclines to macrolides in older patients with community-acquired pneumonia?
Comment in
-
Reply to "Are there reasons to prefer tetracyclines to macrolides in older patients with community-acquired pneumonia?".Antimicrob Agents Chemother. 2013 Aug;57(8):4094. doi: 10.1128/AAC.00864-13. Antimicrob Agents Chemother. 2013. PMID: 23858064 Free PMC article. No abstract available.
Comment on
-
Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection.Antimicrob Agents Chemother. 2013 May;57(5):2326-32. doi: 10.1128/AAC.02176-12. Epub 2013 Mar 11. Antimicrob Agents Chemother. 2013. PMID: 23478961 Free PMC article.
References
-
- Fernández-Sabé N, Carratalà J, Rosón B, Dorca J, Verdaguer R, Manresa F, Gudiol F. 2003. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine (Baltimore) 82:159–169 - PubMed
-
- Welte T, Kohnlein T. 2009. Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network. Semin. Respir. Crit. Care Med. 30:127–135 - PubMed
-
- Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Jr, Musher DM, Niederman MS, Torres A, Whitney CG. 2007. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 44(Suppl. 2):S27–S72 - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
